From: Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations
Parameter
Peak area (mean±SD)
%RSD
Flow rate minus
1310994±4100.3
0.3
Flow rate plus
786560.8±2684.2
Mobile phase minus
962983.3±3338.3
Mobile phase plus
995949.2±9458.3
0.9
Thermal minus
988393.2±5545.8
0.6
Thermal plus
959826.3±1235
0.1